Pharma Operations
Field Guide
Batches fail. Deviation backlogs grow. COPQ quietly drains millions.
Everything here comes from real turnarounds inside pharmaceutical manufacturing.
Browse by topic
What Is the Cost of Poor Quality (COPQ) in Pharmaceutical Manufacturing?
The hidden financial drain that most pharma sites don't measure — and can't fix. This article defines COPQ in operational terms, shows how to quantify it from your existing data, and explains why it's the single most important number for a recovery program.
Read the article →Core Topics
COPQ & Cost Recovery
Quantify, track, and eliminate the hidden costs of poor quality in your operations.
Batch Execution
Restore batch reliability and build the systems that prevent repeat failures.
Deviation Investigations
Close the loop on deviations faster — with root cause that actually sticks.
Digital Manufacturing
How digital tools and systems support execution discipline at scale.
Featured Insights
Exposing the Hidden Factory: How COPQ Reveals Capacity Constraints
March 18, 2026 • By Mike Barlow
The Hidden Factory represents unmeasured capacity consumed by internal failure activities such as deviation investigations, production rework, and documentation errors. While these activities are tracked operationally, their economic impact is rarely quantified. Applying the Cost of Quality framework translates this consumption into financial terms, providing a basis for capacity recovery and risk-informed prioritization aligned with ICH Q9 and Q10.
Latest Insights
GMPWit™ Whitepaper | Structured Productivity in GMP Environments
March 19, 2026 • By Paul Van Buskirk, Mike Barlow
GMPWit™ introduces structured productivity to GMP environments, improving how deviation investigations, CAPAs, and operational work are created—without impacting validated systems or regulatory compliance.
BatchTrak™: Regulatory Alignment with ISPE and GAMP 5
March 16, 2026 • By Paul Van Buskirk, Mike Barlow
This whitepaper explains how the BatchTrak™ Manufacturing Operations Management platform aligns with ISPE Baseline Guide Volume 5 and GAMP 5 risk-based computerized system guidance for regulated pharmaceutical environments.
What Is the Cost of Poor Quality in Pharmaceutical Manufacturing?
March 10, 2026 • By Paul Van Buskirk
Cost of Poor Quality (COPQ) represents the hidden financial losses created when pharmaceutical manufacturing systems fail to execute consistently. While many sites track deviations, investigations, and batch failures, few translate those operational issues into financial impact. In many pharmaceutical organizations, COPQ quietly represents 25–40% of operational cost. Understanding where those losses originate is the first step toward restoring execution stability and recovering lost manufacturing capacity.
Dashboards Don’t Stop Debris
February 26, 2026 • By Paul Van Buskirk
Dashboards were never meant to be decorative. The original dashboard existed to stop debris before it reached the passenger. Modern business dashboards do the opposite — they measure the mess after it hits. In pharmaceutical manufacturing, that mess shows up as lost batches, deviation backlog, delayed disposition, and rework — the true drivers of Cost of Poor Quality. Visibility alone does not prevent failure. Structural correction does.
How to Calculate Your Facility's True COPQ (Free Calculator)
July 24, 2025 • By Mike Barlow, Paul Van Buskirk
Cost of Poor Quality (COPQ) can quietly erode margins in biopharma operations through rework, deviations, delays, and batch losses. This post breaks down the four key components of quality cost—prevention, appraisal, internal failure, and external failure—and introduces a free COPQ calculator to help you estimate the true financial impact and identify opportunities for ROI.
BatchTrak - Is it an Obeya Room?
July 12, 2025 • By Paul Van Buskirk
What is an Obeya Room? An Obeya room (from the Japanese word "Obeya" 大部屋, meaning "big room") is a centralized, physical or digital space used for collaborative project management and visual coordination, especially in Lean and Agile environments.
Turn Execution Instability Into Operational Control
Discover how GMPKit helps pharmaceutical manufacturers reduce Cost of Poor Quality, restore batch reliability, and stabilize execution in 90–120 days.